Related content

Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor

By Han Dan-Dan   Wang Yun   Zhang Xin-Hua   Liu Jin-Rong   Wang Huai-Liang  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 4, 2012-04 ,pp. : 445-454

NRC Research Press

Access to resources Recommend Favorite

Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia

By Sherlock Laurie G.   Trumpie Ashley   Hernandez-Lagunas Laura   McKenna Sarah   Fisher Susan   Bowler Russell   Wright Clyde J.   Delaney Cassidy   Nozik-Grayck Eva  

Antioxidants, Vol. 7, Iss. 3, 2018-03 ,pp. : 42-42

MDPI

Access to resources Recommend Favorite

Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1–dependent pathway

By Zhang Wei-hua   Zhang Yun-jian   Liu Chun-ping   Yu Bing-xiang   Lu Wei-xuan  

Experimental Lung Research, Vol. 37, Iss. 8, 2011-09 ,pp. : 492-499

Informa Healthcare

Access to resources Recommend Favorite

Allergic Airway Inflammation Initiates Long-Term Vascular Remodeling of the Pulmonary Circulation

By  

International Archives of Allergy and Immunology, Vol. 149, Iss. 3, 2009-02 ,pp. : 251-258

Karger

Access to resources Recommend Favorite

Effects of Atorvastatin and Losartan on Monocrotaline-Induced Pulmonary Artery Remodeling in Rats

By Xie Liangdi   Lin Peisen   Xie Hong   Xu Changsheng  

Clinical and Experimental Hypertension, Vol. 32, Iss. 8, 2011-12 ,pp. : 547-554

Informa Healthcare

Access to resources Recommend Favorite